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value of C5 to predict MI on the efficacy of BDT on cough was solution number
of 4.5 (2.8 mmol/L) with a sensitivity of 0.81 and specificity of 0.72.
Conclusions: Measurement of C5 may be useful for predicting efficacy of BDT
on chronic non-productive cough, in other words for diagnosis of CVA.
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Systemic inflammation in COPD: Is there a link with body composition?
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Introduction: COPD is characterized by a low grade systemic inflammation which
has an effect on body composition. We examined the relationship between systemic
inflammation and body composition using the Body Mass Index (BMI) and Fat
Free Mass Index (FFMI).
Methods: A cohort of 37 stable COPD patients (GOLD I-IV) was included. BMI
was calculated as weight/height2 and the FFMI as fat free mass/height2. Systemic
inflammation was visualized by expression of activation markers on peripheral
blood neutrophils using flow cytometry.
Results: The responsiveness of neutrophils for formyl peptides (like fMLF) is
one of the most sensitive markers for detecting in vivo activation of neutrophils.
Peripheral blood neutrophils are less responsive for fMLF under conditions of
systemic inflammation, which is associated with disease severity. This responsive-
ness in the context of expression of CD11b and the active form of FcγRII was
positively correlated with BMI (Table 1). We also found that CCR3, a marker
mainly expressed on pulmonary neutrophils correlated with BMI. In addition, a
positive correlation (Table 1) between FFMI and BMI was found in COPD patients.
Table 1. Indices of systemic inflammation correlate with a low BMI
Correlation between BMI Sig (2-tailed)
FFMI 0.870 0.000
Active form of FcγRII after fMLF stimulation 0.422 0.012
CD11b after fMLF stimulation 0.415 0.013
CCR3 –0.402 0.017
Conclusion: A low BMI is associated with a low grade systemic inflammation in
COPD patients visualized by systemic activation of neutrophils. In COPD patients
the FFMI correlated with BMI, which suggests that the systemic inflammation in
COPD patients is associated with a muscle wasting phenotype.
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Objectives: Although the effect of comorbidities on morbidity and mortality of
COPD is better understood, the discussion about the role of systemic inflamma-
tion on development of comorbidities is going on. We aimed to investigate the
relationship between systemic inflammation and comorbidities in patients with
COPD.
Methods: Comorbidities, systemic and local inflammation markers were in-
vestigated in 50-stable COPD patients and 42-healthy adults who admitted
to our out-patient clinic. Venous blood samples for markers of systemic
inflammation (CRP,fibrinogen,AAT, TNF-α, sTNF-R, IL-1, IL-6, IL-8, neu-
trophils,lymphocytes,eosinophils) and induced sputum samples for local inflamma-
tion markers (TNF-α, IL-6, neutrophils, lymphocytes, eosinophils) were examined.
Results: At least one comorbidity was determined in 80% of patients with COPD
and 47.6% in the controls. The depression, cachexia, pulmonary hypertension and
prevalence of coronary artery disease in patients with COPD were higher than
the controls (p<0.05).All markers of systemic inflammation and local inflam-
mation, except serum mean IL-6 level and mean percentage of peripheral blood
eosinophils, were significantly found higher in patients with COPD. In addition,
the mean serum TNF-α and IL-8 levels were found to be associated with presence
of comorbidity in patients with COPD. The determined comorbidities which are
anxiety, depression, anemia, heart disease, osteoporosis and metabolic syndrome
were found to be associated with one or more systemic inflammatory markers.
Conclusion: The observed comorbidities in COPD is closely related to systemic
inflammation however we think that the exact mechanism of each comorbidity
needs to be further investigated.
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Introduction: The aim of our study was to determine the relationship between body
mass index (BMI), alveolar nitric oxide (CaNO), and the health status of asthmatics
by applying the quality of life questionnaire Sydney-modified (AQLQ-S).
Material and methods: We studied 139 asthmatics (GINA) between 15 and 75
yr of age (men 45 and women 94) and several degrees of severity. We measured
anthropometric variables, baseline spirometry, and nitric oxide exhaled (eNO) at
multiple flows (50, 100, 150, 200 and 250 ml/s). Bronchial nitric oxide flux (JaNO)
and CaNO were assessed according to Tsoukias model. All patients completed the
AQLQ-S questionnaire. For comparisons between two groups, T-student test was
used. The relations between NO parameters and other markers were analyzed with
partial correlations adjusted for asthma severity.
Results: The mean BMI was 26.46±4.97 kg/m2,CaNO 3.89±4,7 ppb and JaNO
2401±2307 nl/sec.There were no statistically significant differences in values of
CaNO and JaNO between obese asthmatic group and non obese. The AQLQ-
S scores obtained were (mean ± SD): total score: 5.62±1.08; shortness of
breath: 5.73±1.14; mood: 5.21±1.24, social restriction: 5.92±1.25; and concern:
5.69±1.10
Correlations between BMI and AQLQ-S scores
Total score Shortness of breath Mood Social restriction Concern
BMI –0,26 (p=0,011) –0,30 (p=0,004) –0,15 (p=0,13) –0,30 (p=0,003) –0,13 (p=0,20)
Conclusions: Obesity determines deterioration in the quality of life of patients
with asthma especially in two dimensions: 1) shortness of breath and 2) social re-
striction. CaNO and JaNO show no relation to the inflammatory state that involves
obesity and have no expression in the health questionnaire score used.
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Background: High sensitive CRP is used as a marker of systematic inflammation
in COPD. Results have shown an inverse relation between serum hs-CRP and
FEV1, except for small study which did not report any correlation between hs-CRP
level and FEV1. However, we hypothesize that the raised hs-CRP is not closely
related to the multiple consequences of COPD. CAT is a simple questionnaire for
assessing and monitoring COPD. Thus, this study was undertaken to investigate the
correlations between CAT score and SPO2 , FEV1, BODE index, and exacerbation
rate, and compare it with the correlations to the serum hs-CRP.
Method: We studied 60 patients with stable COPD and 15 normal subjects as a
control group. SPO2 , BODE index, pulmonary function test and exacerbation rate
were determined in COPD patients. Serum level of hs-CRP was measured in all
patients and the control group. Then, the CAT questionnaire was completed by
patients.
Results: Hs-CRP level was significantly raised in patients (p=0.005). In these
patients, correlations of hs-CRP level with BODE index appeared significant
(p=0.008). However, the correlation between hs-CRP with SPO2 and FEV1 did not
appear significant (p=0.47, p=0.17 respectively). Also, the CAT score correlations
with SPO2, FEV1, BODE index, and exacerbation rate in the previous year were
all found to be significant (p=0.000, p=0.000, p=0.000, p=0.017, respectively).
Conclusion: We conclude that SPO2, FEV1, BODE index and exacerbation rate
are more correlated with the CAT scores than with the serum level of hs-CRP
in stable COPD patients. The findings of this study should be considered in
management of stable COPD.
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